Our partner is dedicated to developing therapies for neurological diseases, with a strong focus on conditions like Alzheimer's, multiple sclerosis, and spinal muscular atrophy. Their innovative treatments aim to address critical unmet medical needs and improve the lives of patients living with these challenging conditions.

This critical hire drove overall medical safety evaluation for global investigational products and clinical development programs. They participated in FDA and other health authority safety interactions and responses with support from the Chief Medical and Regulatory Officers. They were also accountable for all aspects of the global drug safety function, including the development and delivery of a quality Pharmacovigilance system for assigned products and activities.